Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026)
Hims & Hers Health (HIMS) posted Net Cash Flow of -$4.0 million for Q1 2026, up 96.69% sequentially from -$119.9 million in Q4 2025, and down 107.45% YoY from $53.3 million in Q1 2025.
Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Net Cash Flow for 8 years, with the latest figure at -$4.0 million in Q1 2026.
- Quarterly Net Cash Flow fell 107.45% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.6 million (down 131.13% YoY) and the FY2025 annual result came in at $4.7 million, down 96.24% from the prior year.
- Net Cash Flow grew to -$4.0 million in Q1 2026 per HIMS's latest filing, from -$119.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $849.0 million in Q2 2025 and troughed at -$777.7 million in Q3 2025.
- A 5-year average of $8.8 million and a median of $6.8 million in 2022 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 3428.68% in 2025, down 2258.26% in 2025.
- Over 5 years, Net Cash Flow stood at -$11.2 million in 2022, then surged by 446.44% to $38.7 million in 2023, then jumped by 43.43% to $55.5 million in 2024, then tumbled by 315.91% to -$119.9 million in 2025, then surged by 96.69% to -$4.0 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$4.0 million, -$119.9 million, and -$777.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 390.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 390.35 Mn |
| Jun 30, 2026 | 390.35 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Mar 31, 2024 | 8.57 Mn |